GKOS Novinky na Forexu

Pharmaceutical company Glaukos Corp. (GKOS) announced Thursday the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg.